RhumbLine Advisers’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $81.4K | Sell |
8,975
-698
| -7% | -$6.33K | ﹤0.01% | 3586 |
|
2025
Q1 | $92.3K | Buy |
9,673
+3,168
| +49% | +$30.2K | ﹤0.01% | 3413 |
|
2024
Q4 | $73K | Buy |
6,505
+203
| +3% | +$2.28K | ﹤0.01% | 3560 |
|
2024
Q3 | $90.6K | Sell |
6,302
-497
| -7% | -$7.14K | ﹤0.01% | 3525 |
|
2024
Q2 | $117K | Buy |
+6,799
| New | +$117K | ﹤0.01% | 3469 |
|